Bevacizumab 400mg/16ml (DR. REDDY’S)
Bevacizumab 400mg/16ml Injection (Dr. Reddy’s) is a targeted biological therapy containing bevacizumab, designed to support cancer treatment under medical supervision. It belongs to the monoclonal antibody class and works by targeting vascular endothelial growth factor (VEGF), a protein involved in the formation of new blood vessels that support tumor growth. This injection is used as part of approved treatment protocols for certain cancers, including colorectal, lung, kidney, ovarian, and other cancers depending on clinical requirements. It is administered by qualified healthcare professionals with proper dosage evaluation. Always follow your oncologist’s advice before using this medication.
Description
Bevacizumab 400mg/16ml Injection (Dr. Reddy’s) contains bevacizumab, a recombinant monoclonal antibody used as a targeted therapy in oncology care. This medication helps manage specific types of cancer by targeting vascular endothelial growth factor (VEGF), a protein that supports the growth of new blood vessels. By blocking VEGF activity, the therapy helps reduce the blood supply that tumors require for growth and progression.
Doctors prescribe this injection as part of combination treatment plans for various cancers, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, cervical cancer, and other approved cancer conditions. Healthcare professionals administer this medicine through intravenous infusion after evaluating the patient’s medical condition, treatment goals, and response to therapy.
Bevacizumab 400mg/16ml Injection provides a targeted approach that focuses on specific biological pathways involved in tumor development. Oncologists carefully determine the appropriate dosage and treatment schedule based on factors such as cancer type, overall health, and other ongoing therapies. Patients should receive this medication only under expert medical supervision to ensure safe and effective use.
Dr. Reddy’s manufactures this injection following quality standards to support reliable oncology treatment. Patients should discuss their complete medical history, current medications, and possible risks with their healthcare provider before starting therapy. Regular monitoring helps doctors evaluate treatment response and manage any potential side effects during the course of treatment.
Bevacizumab 400mg/16ml Injection plays an important role in modern targeted cancer therapy by helping healthcare providers address specific cancer pathways. Patients should use this medication strictly according to their oncologist’s prescription and medical guidance.
- Product Name: Bevacizumab 400mg/16ml Injection
- Brand: Dr. Reddy’s Laboratories
- Active Ingredient: Bevacizumab
- Strength: 400mg/16ml
- Drug Class: Monoclonal Antibody / Targeted Cancer Therapy
- Therapeutic Category: Oncology Medication
- Mechanism: VEGF (Vascular Endothelial Growth Factor) inhibitor
- Dosage Form: Intravenous Infusion Injection
- Administration: Given by healthcare professionals under medical supervision
- Storage: Store according to manufacturer and healthcare provider instructions
- Prescription Status: Prescription-only medicine
